Altium Capital Management LP Eye Point Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $3,979 - $6,476	-459 Reduced 0.2%	224,541 $2.73 Million
Q4 2021 Feb 14, 2022	SELL	$10.18 - $18.4 $1.48 Million - $2.68 Million	-145,551 Reduced 39.28%	225,000 $2.75 Million
Q2 2021 Aug 13, 2021	BUY	$8.69 - $11.08 $705,932 - $900,083	81,235 Added 28.08%	370,551 $3.33 Million
Q1 2021 May 06, 2021	BUY	$8.89 - $14.92 $2.57 Million - $4.32 Million	289,316 New	289,316 $2.94 Million

163

58.2M

224K

1.41M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $272M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.